(R)-2-(9-cyclopentyl-6-(4-(pyridin-2-yl)benzylamino)-9H-purin-2-ylamino)butan-1-ol

ID: ALA2402949

PubChem CID: 73347509

Max Phase: Preclinical

Molecular Formula: C26H31N7O

Molecular Weight: 457.58

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C3CCCC3)c2n1

Standard InChI:  InChI=1S/C26H31N7O/c1-2-20(16-34)30-26-31-24(23-25(32-26)33(17-29-23)21-7-3-4-8-21)28-15-18-10-12-19(13-11-18)22-9-5-6-14-27-22/h5-6,9-14,17,20-21,34H,2-4,7-8,15-16H2,1H3,(H2,28,30,31,32)/t20-/m1/s1

Standard InChI Key:  FLIJBHQHRINPMX-HXUWFJFHSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   15.4448   -8.3787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2323   -8.6286    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4448   -7.5495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7283   -8.7912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2323   -7.2913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0158   -7.5495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0158   -8.3787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7283   -7.1370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7198   -7.9620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7199   -6.3122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2950   -8.7912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4907   -9.4160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4407   -5.8997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4324   -5.0789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5825   -8.3787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1576   -8.3787    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8701   -8.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7158   -4.6789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1407   -4.6664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5825   -7.5537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8576   -7.1413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1323   -3.8498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7074   -3.8539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4199   -3.4415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0054  -10.0880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4944  -10.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2819  -10.4986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2796   -9.6699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4199   -2.6198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1351   -2.2063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1336   -1.3822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4178   -0.9704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7018   -1.3890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7069   -2.2117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  1  2  0
  5  3  1  0
  6  7  2  0
  7  4  1  0
  8  3  2  0
  9  2  1  0
 10  8  1  0
 11  7  1  0
 12  2  1  0
 13 10  1  0
 14 13  1  0
 15 11  1  0
 16 17  1  0
 17 15  1  0
 18 14  2  0
 19 14  1  0
 15 20  1  1
 21 20  1  0
 22 19  2  0
 23 18  1  0
 24 22  1  0
  8  6  1  0
  9  5  2  0
 23 24  2  0
 27 28  1  0
 25 26  1  0
 12 25  1  0
 26 27  1  0
 28 12  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 24 29  1  0
M  END

Associated Targets(Human)

G-361 (890 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOS (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1 (3927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 457.58Molecular Weight (Monoisotopic): 457.2590AlogP: 4.80#Rotatable Bonds: 9
Polar Surface Area: 100.78Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.26CX LogP: 4.29CX LogD: 4.29
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.33Np Likeness Score: -0.82

References

1. Gucký T, Jorda R, Zatloukal M, Bazgier V, Berka K, Řezníčková E, Béres T, Strnad M, Kryštof V..  (2013)  A novel series of highly potent 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitors.,  56  (15): [PMID:23829517] [10.1021/jm4006884]

Source